Local Infiltration Analgesia in Total Knee Arthroplasty

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: All

Summary

40 patients ASA I-III, undergoing total knee arthroplasty were randomly assigned, into one of two groups, namely group LIA (n=20), where local infiltration analgesia would be administered intraoperatively; and group sham LIA (n=20), where sham injections of normal saline would be administered. All patients received a standardized multimodal approach, including pregabalin, adductor canal peripheral nervous blockade, spinal anaesthesia, paracetamol, and PCA with morphine. Morphine consumption during the first 24 hours postoperatively was measured and additionally the investigators recorded: Time of morphine first dose administration, NRS scores in static and dynamic conditions in 6 hours, 12 hours, 18 hours and 24 hours postoperatively, complications, patient satisfaction and duration of hospitalization.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asklepieion Voulas General Hospital
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Physical status according to American Society of Anesthesiologists (ASA) I-III

• Patients scheduled for total knee arthroplasty

Exclusion Criteria:

• Contraindication for central and/or peripheral nervous blockade

• Reoperation on previous total knee arthroplasty

• History of allergic or other adverse reactions on the agents used in the study

• Chronic opioid or gabapentinoid use

• Serious psychiatric, mental and cognitive disorders

• Language barrier

• Difficulty in understanding or using a patient controlled analgesia device